Alnylam Pharmaceuticals Long Term Deferred Charges (Quarterly) Insights

Alnylam Pharmaceuticals, Inc. (ALNY)

400.17 +2.52 (+0.63%) USD | NASDAQ | Jan 02, 16:00

398.11 -2.06 (-0.51%) Pre-Market: 09:15

View Long Term Deferred Charges (Quarterly) for ALNY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial